Cargando…

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets

BACKGROUND: Triple negative breast cancer (TNBC) is high-risk due to its rapid drug resistance and recurrence, metastasis, and lack of targeted therapy. So far, no molecularly targeted therapeutic agents have been clinically approved for TNBC. It is imperative that we discover new targets for TNBC t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaosheng, Guda, Chittibabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265847/ https://www.ncbi.nlm.nih.gov/pubmed/27472710 http://dx.doi.org/10.1097/MD.0000000000004321

Ejemplares similares

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets: Erratum
Publicado: (2016)

MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1
por: Lee, Soo Jung, et al.
Publicado: (2021)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Trends of triple negative breast cancer research (2007–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016)

Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)

Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells
por: Kong, Yan, et al.
Publicado: (2020)

Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology
por: Chu, Meiling, et al.
Publicado: (2023)

Classification of breast cancer patients using somatic mutation profiles and machine learning approaches
por: Vural, Suleyman, et al.
Publicado: (2016)

MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy
por: Zhao, Jingwei, et al.
Publicado: (2023)

Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017)

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature
por: Ogata, Hideaki, et al.
Publicado: (2015)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer
por: Zhang, Shujuan, et al.
Publicado: (2023)

Triple metachronous primary cancer of uterus, colon, and breast cancer: A case report and review of the literature
por: Li, Guanqiao, et al.
Publicado: (2020)

Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma
por: Li, Shuzhen, et al.
Publicado: (2021)

Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction
por: Yang, Yi-Fei, et al.
Publicado: (2021)

Computational Analysis of Transcriptional Circuitries in Human Embryonic Stem Cells Reveals Multiple and Independent Networks
por: Wang, Xiaosheng, et al.
Publicado: (2014)

Breast metastasis from EGFR/ALK negative lung adenocarcinoma: A case report
por: Cao, Liyu, et al.
Publicado: (2020)

Exploring the immunological role and prognostic potential of PPM1M in pan-cancer
por: Zeng, Rongruo, et al.
Publicado: (2023)

Integrated analysis identifies an immune-based prognostic signature for the mesenchymal identity in colorectal cancer
por: Zhang, Bin, et al.
Publicado: (2020)

Classification of triple-negative breast cancers based on Immunogenomic profiling
por: He, Yin, et al.
Publicado: (2018)

Five-hub genes identify potential mechanisms for the progression of asthma to lung cancer
por: Yang, Weichang, et al.
Publicado: (2023)

p-STAT3 expression in breast cancer correlates negatively with tumor size and HER2 status
por: Wang, Yan, et al.
Publicado: (2021)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

MicroRNA expression profiling and target gene analysis in gastric cancer
por: Xu, Chenguang, et al.
Publicado: (2020)

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer
por: Sheng, Mingyan, et al.
Publicado: (2020)

DDX10 and BYSL as the potential targets of chondrosarcoma and glioma
por: Quan, Xuemin, et al.
Publicado: (2021)

Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma
por: Zhang, Weiyi
Publicado: (2023)

Integrative network analyses of transcriptomics data reveal potential drug targets for acute radiation syndrome
por: Moore, Robert, et al.
Publicado: (2021)

Malignancy of Cancers and Synthetic Lethal Interactions Associated With Mutations of Cancer Driver Genes
por: Wang, Xiaosheng, et al.
Publicado: (2016)

Discovering Distinct Functional Modules of Specific Cancer Types Using Protein-Protein Interaction Networks
por: Shen, Ru, et al.
Publicado: (2015)

The PITX gene family as potential biomarkers and therapeutic targets in lung adenocarcinoma
por: Zhang, Chunyi, et al.
Publicado: (2021)

CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021)

Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study
por: Wang, Wei, et al.
Publicado: (2019)

Different histological types of triple metachronous primary lung carcinomas in 1 patient: Case report
por: Kim, Jee Hyuk, et al.
Publicado: (2017)

A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers
por: Goonesekere, Nalin C. W., et al.
Publicado: (2014)

Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer
por: Li, Hui, et al.
Publicado: (2023)

Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients
por: Bai, Zhenzi, et al.
Publicado: (2020)

Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
por: Huang, Can, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vlf94b9v2j8govpocv8oa5r2tr